CXL wins FDA approval, so prepare to code – Ophthalmology Management

Corneal collagen cross-linking is a fairly new procedure to treat certain corneal diseases. As is often the case, there are lots of questions about coverage from third-party payers at this point. This article addresses the following questions: What is corneal collagen cross-linking? What conditions are treated with CXL? Has CXL been approved by the FDA?…

Read More

Laser-assisted keratoplasty: Know the coding details – Ophthalmology Management

Keratoplasty, another name for corneal transplant, is commonly performed using a trephine, but it could also be performed with a femtosecond (FS) laser. There are some clinical advantages to using the latter, but be sure to check for coverage first. This article addresses the following questions: What is femtosecond laser-assisted keratoplasty? What are the indications…

Read More

Reading the glaucoma reimbursement tea leaves – Ophthalmology Management

This month we will review trends in glaucoma reimbursement — past and future — in the larger context of eye care. In the United States, the most common eye diseases are age-related macular degeneration, cataract, glaucoma and diabetic retinopathy. As baby boomers age, their demands for healthcare and eye care will grow. Some ocular conditions…

Read More

2016 bulletin on fee schedules, codes – Ophthalmology Management

The new year, of course, brings changes to the coding landscape. This month, we will look at changes to the Medicare fee schedules, as well as coding changes for 2016. This article addresses the following questions: What happened with the Medicare Physician Fee Schedule as of Jan. 1? What about ambulatory surgery center facility fees…

Read More

Overpaid? Send it back, and quickly – Ophthalmology Management

Recent actions by payers and law enforcement have changed the landscape regarding refunding overpayments — and not in ways that favor practices. Importantly, two recent precedents make it clear that you no longer can “investigate whether the overpayment is real” before determining that the 60-day window is implicated; it begins immediately. Here is an update…

Read More

Alternative ophthalmic drug delivery systems – Ophthalmology Management

For most conditions, ophthalmic medications are administered by the patient, be they drop or ointment, and require proper times and intervals for successful results. Unfortunately, some patients have a hard time following instructions, even with the best of intentions, and are not compliant. Then treatment and outcomes are doomed to be suboptimal. So, alternative drug…

Read More

The once-in-awhile UBM test is uncommon no longer – Ophthalmology Management

Once an uncommon test, ultrasonic biomicroscopy has been garnering increased interest from some ophthalmologists. If you’re one of them, here’s what you need to know about coding for it. This article addresses the following subjects: What is ultrasonic biomicroscopy? What are the indications for UBM? What CPT code describes UBM? What documentation is required to…

Read More

When ECP is your choice – Ophthalmology Management

When glaucoma medications fail or the patient cannot tolerate them, surgeons have various surgical procedures they can turn to — and then bill for. Here’s help with the latter task for one glaucoma surgery option when others have failed: endoscopic cyclophotocoagulation. This article addresses the following subjects: What is endoscopic cyclophotocoagulation? What are the indications?…

Read More

When floaters require treatment – Ophthalmology Management

Vitreous floaters can be annoying, but most do not require treatment. Let’s discuss what you need to know to obtain reimbursement when treatment is necessary. This article addresses the following subjects: What is the medical rationale for treating vitreous floaters? What factors argue in favor of lasering vitreous floaters? Is laser treatment of vitreous floaters…

Read More